These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26576319)

  • 1. Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease.
    Vallderiola F; Compta Y; Aparicio J; Tarradellas J; Salazar G; Oliver JM; Callén A; Delgado T; Nobbe F
    Parkinsons Dis; 2015; 2015():475630. PubMed ID: 26576319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
    Trenkwalder C; Kies B; Rudzinska M; Fine J; Nikl J; Honczarenko K; Dioszeghy P; Hill D; Anderson T; Myllyla V; Kassubek J; Steiger M; Zucconi M; Tolosa E; Poewe W; Surmann E; Whitesides J; Boroojerdi B; Chaudhuri KR;
    Mov Disord; 2011 Jan; 26(1):90-9. PubMed ID: 21322021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study.
    Pagonabarraga J; Piñol G; Cardozo A; Sanz P; Puente V; Otermín P; Legarda I; Delgado T; Serrano C; Balaguer E; Aguirregomozcorta M; Álvarez R; Kulisevsky JJ
    Parkinsons Dis; 2015; 2015():131508. PubMed ID: 25793143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.
    Bhidayasiri R; Sringean J; Chaiwong S; Anan C; Penkeaw N; Leaknok A; Boonpang K; Saksornchai K; Rattanachaisit W; Thanawattano C; Jagota P
    Parkinsonism Relat Disord; 2017 Nov; 44():124-128. PubMed ID: 28818560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
    Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
    BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto M; Miyamoto T; Tatsumoto M; Watanabe Y; Suzuki S; Iwanami M; Sada T; Kadowaki T; Numao A; Trenkwalder C; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):76-81. PubMed ID: 22534309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson's disease: a meta-analysis.
    Fei L; Zhou D; Ding ZT
    Sleep Med; 2019 Sep; 61():19-25. PubMed ID: 31272824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials.
    Wang HT; Wang L; He Y; Yu G
    J Neurol Sci; 2018 Oct; 393():31-38. PubMed ID: 30099246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study.
    Chung SJ; Kim JM; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
    Expert Opin Pharmacother; 2015 May; 16(7):961-70. PubMed ID: 25846031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study.
    Valldeoriola F; Salvador A; Gómez-Arguelles JM; Marey J; Moya M; Ayuga Á; Ramírez F
    Int J Neurosci; 2018 Apr; 128(4):369-375. PubMed ID: 29249180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
    Hauser RA; Slawek J; Barone P; Dohin E; Surmann E; Asgharnejad M; Bauer L
    BMC Neurol; 2016 Jun; 16():90. PubMed ID: 27267880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson's Disease.
    Park KW; Jo S; Lee SH; Hwang YS; Lee D; Ryu HS; Chung SJ
    J Mov Disord; 2020 Sep; 13(3):205-212. PubMed ID: 32894900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson's disease.
    Wang Y; Yang YC; Lan DM; Wu H-; Zhao ZX
    Sleep Breath; 2017 May; 21(2):319-325. PubMed ID: 27726069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.
    Ceballos-Baumann A; Häck HJ
    Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease.
    Ray Chaudhuri K; Martinez-Martin P; Rolfe KA; Cooper J; Rockett CB; Giorgi L; Ondo WG
    Eur J Neurol; 2012 Jan; 19(1):105-13. PubMed ID: 21699627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and profile of nocturnal disturbances in Chinese patients with advanced-stage Parkinson's disease: a cross-sectional epidemiology study.
    He G; Liu CF; Ye Q; Liu Z; Jin M; Shang H; Chen L; Tuo H; Jiang H; Cai J; Joshi K; Cooper J; Zi L; Chen S
    BMC Neurol; 2021 May; 21(1):194. PubMed ID: 33980158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
    Ray Chaudhuri K; Martinez-Martin P; Antonini A; Brown RG; Friedman JH; Onofrj M; Surmann E; Ghys L; Trenkwalder C
    Parkinsonism Relat Disord; 2013 Jul; 19(7):660-5. PubMed ID: 23557594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Sleep Disturbances and Daytime Somnolence in Parkinson's Disease.
    Phattanarudee S; Sangthong S; Bhidayasiri R
    Eur Neurol; 2018; 80(5-6):268-276. PubMed ID: 30731467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
    Pierantozzi M; Placidi F; Liguori C; Albanese M; Imbriani P; Marciani MG; Mercuri NB; Stanzione P; Stefani A
    Sleep Med; 2016 May; 21():140-4. PubMed ID: 27448485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.